Aclaris Therapeutics Stock (NASDAQ: ACRS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 262.000 / 1.773M |
Day Range | - - - |
52 Wk Range | 0.590 - 11.120 |
Market Cap | $89.366M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 9.48% |
Days to Cover | 4.28 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aclaris Therapeutics (NASDAQ: ACRS) through any online brokerage.
Other companies in Aclaris Therapeutics’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Cara Therapeutics (NASDAQ:CARA) and Anebulo Pharmaceuticals (NASDAQ:ANEB).
The latest price target for Aclaris Therapeutics (NASDAQ: ACRS) was reported by HC Wainwright & Co. on Monday, January 22, 2024. The analyst firm set a price target for 0.00 expecting ACRS to fall to within 12 months (a possible -100.00% downside). 16 analyst firms have reported ratings in the last year.
The stock price for Aclaris Therapeutics (NASDAQ: ACRS) is $1.26 last updated Today at March 28, 2024 at 12:54 AM EDT.
There are no upcoming dividends for Aclaris Therapeutics.
Aclaris Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Aclaris Therapeutics.
Aclaris Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.